Airborne and liquid-borne contamination in ventilation can put both patients and equipment at risk. Our filters can be placed at the machine side or the patient side to provide a dependable microbial barrier while maintaining low flow resistance for consistent performance. Unlike most breathing filters, which are not validated for nebulization and often require replacement after each session, the Ultipor® 100 is a high-efficiency option validated for intensive care that enables drug nebulization — reducing waste, lowering costs, and supporting safer, more efficient care.

Using a Pall Medical Ultipor® 50 /55 at the machine end together with Ultipor® 100 at the patient end creates a dry‑gas setup that supports extended filter life in intensive care. In this configuration, the Ultipor® 50/55 can remain in service for up to 7 days, while the Ultipor® 100 can be safely used for up to 48 hours when nebulization is not applied.

This combined approach not only protects ventilators and patients through high‑efficiency removal of airborne and liquid‑borne contaminants, but also reduces filter change frequency, lowers waste, and supports more efficient ICU workflows.

Our Clinical Specialist Team provides hands-on hospital evaluations and bedside guidance. By converting findings into clear recommendations and real-time troubleshooting, we accelerate decisions, reduce deployment risk, and keep patient care running smoothly.